Latest filing published 06 Jan 2020 for Insight Molecular Diagnostics Inc., €4.6M.
Filing timeline
BuySaleInsider track record
Lineage Cell Therapeutics, Inc.: trading record in brief
This profile gathers the share dealings of Lineage Cell Therapeutics, Inc. in Insight Molecular Diagnostics Inc. Over a trading history stretching from 11 September 2019 to 2 January 2020, the count stands at 2 filings.
No open-market purchase appears, only 2 sales worth €10.6M. In 2020 alone, the filings show no purchases and 1 sale.
Most recently, on 6 January 2020, the filings show an open-market sale worth €4.6M in Insight Molecular Diagnostics Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lineage Cell Therapeutics, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,383,090 shares@ US$2.1643.2% of flowCommon Stock, no par valueSEC:0001493152-20-000240:0
- 4,000,000 shares@ US$1.6656.8% of flowCommon Stock, no par valueSEC:0001493152-19-014109:0
2 of 2 declarations
